ENDO USA, Inc.
NDC labeler codes: 0254, 42023, 52244, 63481, 66887, 67979
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- TheophyllineTheo-24 · 4 products
- AlprostadilEdex, Caverject, Caverject Impulse · 3 products
- LevothyroxineTirosint, Tirosint Sol, Unithroid · 3 products
- PosaconazoleNoxafil · 2 products
- TestosteroneVogelxo, Testopel, Natesto Nasal Gel · 2 products
- Ertapenem sodiumInvanz · 2 products
- Leuprolide acetateVabrinty, Eligard, Fensolvi · 1 product
- ValrubicinValstar · 1 product
- Histrelin acetateSupprelin La · 1 product
- Colistin sulfate, neomycin sulfate, thonzonium bromide and hydrocortisone acetateCortisporin Tc · 1 product
- Testosterone undecanoateKyzatrex, Jatenzo, Tlando · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| June 9, 2025 | ANDA217437 | Leuprolide acetate LEUPROLIDE ACETATE | Ph Health |
| March 5, 2014 | NDA022219 | Testosterone undecanoate AVEED | Endo Operations |
| November 25, 2013 | NDA205053 | Posaconazole NOXAFIL | Merck Sharp Dohme |
| June 24, 2011 | NDA202231 | Levothyroxine LEVOTHYROXINE SODIUM | Fresenius Kabi USA |
| May 3, 2007 | NDA022058 | Histrelin acetate SUPPRELIN LA | Endo Operations |
| September 15, 2006 | NDA022003 | Posaconazole NOXAFIL | Schering |
| October 31, 2002 | NDA021454 | Testosterone TESTIM | Endo Operations |
| November 21, 2001 | NDA021337 | Ertapenem sodium INVANZ | Msd Sub Merck |
| September 25, 1998 | NDA020892 | Valrubicin VALSTAR PRESERVATIVE FREE | Endo Operations |
| June 12, 1997 | NDA020649 | Alprostadil EDEX | Endo Operations |
| August 22, 1983 | ANDA087943 | Theophylline THEO-24 | Endo Operations |
| July 13, 1972 | ANDA080911 | Testosterone TESTOPEL | Endo Operations |
| May 17, 1962 | NDA050356 | Colistin sulfate, neomycin sulfate, thonzonium bromide and hydrocortisone acetate COLY-MYCIN S | Ph Health |
| — | ANDA081034 | Theophylline | — |
| — | ANDA087942 | Theophylline | — |
| — | ANDA087944 | Theophylline | — |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2017
-
February 22, 2017 · Class II · Terminated · D-0512-2017 · Alprostadil
Lack of Assurance of Sterility: Defective container resulting in the lack of sterility assurance. ok thanks
Edex (alprostadil for injection) 10mcg, packaged in a 2 pack carton, Rx only, Manufactured in Germany for: Actient Pharmaceuticals, LLC, Lake Forest, Illinois 60045; NDC 52244-010-02.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026